web analytics

Welcome to Discuva

Discuva is a drug discovery company focused on the creation of Next Generation targeted antimicrobials against new emerging and drug-resistant bacterial pathogens.

From a study of 114 countries, the World Health Organisation has predicted a future where all current antibiotic drugs are ineffective. In this ‘post-antibiotic era’ a simple scratch or routine surgical procedure will be a potentially life-threatening event.

At Discuva, using ground-breaking new technologies, we are successfully developing completely new classes of antibiotics which we believe will play a major role in protecting society from the forthcoming threat promised by the emergence of drug-resistant bacteria.

Upcoming Events

Latest Tweets from @DiscuvaLtd

Discuva Ltd @DiscuvaLtd
RT @NASA: Bacteria may mutate more rapidly in space, helping to predict how pathogens become resistant to antibiotics: https://t.co/F8TwJ9a
Discuva Ltd @DiscuvaLtd
David Williams (CEO) @DiscuvaLtd will be presenting at #Superbugs & #Superdrugs on 21st March 2017 @SMi_Group
Discuva Ltd @DiscuvaLtd
RT @WHO: Great news! The @UN Secretary-General establishes the Interagency Coord. Group on #AntimicrobialResistance today https://t.co/c0EN